Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

November 17, 2014

Mitchell et al v. AbbVie, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 24, 2018

    AbbVie Disputes $3M AndroGel Verdict In MDL Bellwether

    AbbVie Inc. asked an Illinois federal court Monday to grant a new trial, enter a judgment against the patient who brought suit or overturn a $3.2 million verdict that found the drugmaker's testosterone replacement therapy AndroGel caused the patient's heart attack, saying the jury's finding was contradictory.

16 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login